2017
DOI: 10.5737/236880762713342
|View full text |Cite
|
Sign up to set email alerts
|

Development and validation of an individualized survivorship care plan (ISCP) for women with endometrial cancer during the transition of the end of active treatment to the cancer survivorship

Abstract: ABSTRACT

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2018
2018
2019
2019

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“… 22 Many barriers to making the survivorship care plan an integral part of existing practice have been reported, including low “buy-in” from primary care professionals 23 and the lack of dedicated resources. 24 , 25 There are grounds for believing that similar issues could be raised in the development and implementation of an intervention designed to promote RTW in primary care. For this reason, it is necessary to contextualize the intervention to locate levers and barriers, assign priorities, and attempt to understand their synergy.…”
Section: Introductionmentioning
confidence: 99%
“… 22 Many barriers to making the survivorship care plan an integral part of existing practice have been reported, including low “buy-in” from primary care professionals 23 and the lack of dedicated resources. 24 , 25 There are grounds for believing that similar issues could be raised in the development and implementation of an intervention designed to promote RTW in primary care. For this reason, it is necessary to contextualize the intervention to locate levers and barriers, assign priorities, and attempt to understand their synergy.…”
Section: Introductionmentioning
confidence: 99%
“…Described as a mismatch between what individuals perceive as necessary to optimize their health and the care and International research has documented the myriad of challenges experienced, often unexpectedly, in the aftermath of initial cancer treatment [22,23]. These include feeling unprepared [24][25][26][27], experiencing uncertainty [24,26,28], fear of recurrence [24,26,28,29] and being insufficiently informed about late treatment effects [24,26], self-management strategies and local support services [24]. However, for people affected by haematological cancers, this distinct point in the illness trajectory is still poorly understood, for it remains relatively unexplored.…”
Section: Introductionmentioning
confidence: 99%